PHASEBIO PHARMACEUTICALS INC
(717224109)
Fondsberichterstattung Bestände von PHASEBIO PHARMACEUTICALS INC gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 1,423,256 | $18,673k | Jun 30, 2019 | Aug 14, 2019 | |
| Deerfield Management Company LP Series C | 851,005 | $11,165k | Jun 30, 2019 | Aug 14, 2019 | |
| Farallon Capital Management LLC | 756,961 | $9,931k | Jun 30, 2019 | Aug 14, 2019 | |
| Dafna Capital Management LLC | 200,013 | $2,624k | Jun 30, 2019 | Aug 14, 2019 | |
| Sectoral Asset Management Inc | 176,000 | $2,309k | Jun 30, 2019 | Aug 14, 2019 | |
| EAM Investors LLC | 140,850 | $1,848k | Jun 30, 2019 | Aug 14, 2019 | |
| EAM Global Investors LLC | 87,891 | $1,153k | Jun 30, 2019 | Aug 14, 2019 | |
| Sabby Management LLC | 82,931 | $1,088k | Jun 30, 2019 | Aug 14, 2019 |